4.8 Review

Regulation of Pattern-Recognition Receptor Signaling by HBX During Hepatitis B Virus Infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

STING signaling activation inhibits HBV replication and attenuates the severity of liver injury and HBV-induced fibrosis

Yuqi Li et al.

Summary: Activation of the STING signaling pathway can inhibit HBV replication by epigenetic suppression of cccDNA and alleviate HBV-induced liver fibrosis through the suppression of macrophage inflammasome activation by activating autophagic flux in a chronic HBV mouse model. Targeting the STING pathway may be an important therapeutic strategy to protect against persistent HBV replication and HBV-induced fibrosis.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Review Virology

Cross talk between hepatitis B virus and innate immunity of hepatocytes

Forough Golsaz-Shirazi et al.

Summary: Innate immunity plays a crucial role in controlling viral infections, with recent research identifying the sodium taurocholate co-transporting polypeptide receptor as a specific HBV receptor in human hepatocytes. HBV can evade the innate immune responses of hepatocytes and activating these components may contribute to eradicating HBV infection.

REVIEWS IN MEDICAL VIROLOGY (2022)

Review Immunology

Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors

Koji Onomoto et al.

Summary: RLRs are RNA sensor molecules that play essential roles in innate antiviral immunity by inducing downstream signaling via interactions with various host and viral factors. The signaling mediated by RLRs is regulated by interactions with endogenous RNAs and host proteins, and deregulation can lead to autoimmune and autoinflammatory disorders.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Medicine, General & Internal

HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis

Xiaoyu Xie et al.

Summary: HBeAg activates macrophages via the TLR-2/NF-kappa B signal pathway and further exacerbates hepatic fibrosis by facilitating motility, proliferation, and contraction of HSCs with the help of macrophages.

BMC MEDICINE (2021)

Review Biochemistry & Molecular Biology

The Evolution of STING Signaling and Its Involvement in Cancer

Nimi Vashi et al.

Summary: The cGAS-STING pathway has been primarily characterized as an inflammatory mechanism in response to cytosolic dsDNA, but recent studies indicate its crucial primordial function is to promote autophagy and downstream interferon signaling is a recent evolutionary emergence. This pathway may serve as a crucial regulator of cellular metabolism, potentially linking inflammation to nutrient availability. Future research can further explore its potential role in cancer therapy.

TRENDS IN BIOCHEMICAL SCIENCES (2021)

Review Biochemistry & Molecular Biology

The crosstalk between pattern-recognition receptor signaling and calcium signaling

Fanyun Kong et al.

Summary: The innate immune system serves as the first defense line against pathogens with pattern recognition receptors, while Ca2+ acts as a crucial second messenger in various biological processes. Recent studies have shown that PRR signaling regulates Ca2+ signaling, indicating a potential interplay between the two pathways in controlling innate immune responses.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)

Article Cell Biology

Hepatitis B virus particles activate B cells through the TLR2-MyD88-mTOR axis

Qian Li et al.

Summary: Host immune control is crucial in resolving primary hepatitis B virus (HBV) infections. This study found that TLR2 mRNA accumulation is most impacted during woodchuck hepatitis virus (WHV) infection resolution, with B-cell TLR2 activation playing a key role in HBV infection resolution.

CELL DEATH & DISEASE (2021)

Review Biochemistry & Molecular Biology

Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview

Mohammad Enamul Hoque Kayesh et al.

Summary: Chronic hepatitis B virus (HBV) infection is a major global health problem, and the link between Toll-like receptors (TLRs) and chronic HBV infection is being increasingly recognized. TLR agonists have the potential to enhance the host immune response against HBV infection and improve CHB treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Suppression of hepatitis B virus through therapeutic activation of RIG-1 and IRF3 signaling in hepatocytes

Sooyoung Lee et al.

Summary: Activation of the RIG-I pathway and IRF3 can induce innate immune actions towards the elimination of cccDNA, showing therapeutic benefit in suppressing HBV infection.

ISCIENCE (2021)

Review Biochemistry & Molecular Biology

The cGAS-STING pathway: more than fighting against viruses and cancer

Terigen Bao et al.

Summary: The cGAS-STING pathway plays a crucial role in chronic inflammatory diseases, particularly in relation to lipid metabolism. Current research suggests that targeted therapy for diseases possibly caused by the cGAS-STING pathway shows promising outcomes.

CELL AND BIOSCIENCE (2021)

Article Cell Biology

Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis

Hongjuan You et al.

Summary: The study indicated that vimentin expression is increased in HBX-positive hepatoma cells and HBV-related HCC tissues, correlated with HBX. HBX enhances vimentin expression through LASP1 mediated signal pathways, contributing to EMT, proliferation, and migration of HCC cells.

CELL COMMUNICATION AND SIGNALING (2021)

Review Medicine, General & Internal

Sirtuins as Potential Therapeutic Targets for Hepatitis B Virus Infection

Fanyun Kong et al.

Summary: SIRT proteins are affected by HBV infection, and they regulate HBV replication through a cascade of molecular mechanisms, making targeting SIRTs a potential therapeutic strategy for HBV infection.

FRONTIERS IN MEDICINE (2021)

Review Oncology

The Mechanisms of HBV-Induced Hepatocellular Carcinoma

Yu Jiang et al.

Summary: Hepatocellular carcinoma (HCC) is a common malignancy in which hepatitis B virus (HBV) plays a major role in promoting disease progression and malignant transformation of liver cells. Research on HBV-associated HCC (HBV-HCC) has identified various mechanisms, including HBV gene integration, genomic instability, and activation of cancer-promoting signaling pathways. As research progresses, new mechanisms such as epigenetics, exosomes, autophagy, metabolic regulation, and immune suppression are also being explored for their roles in the occurrence and development of HBV-HCC.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)

Review Cell Biology

Calcium signaling in hepatitis B virus infection and its potential as a therapeutic target

Fanyun Kong et al.

Summary: Calcium acts as a ubiquitous second messenger in HBV infection, elevating cytosolic Ca2+ levels through different channels and promoting viral replication. Targeting Ca2+ signaling is an effective approach for the treatment of HBV infection.

CELL COMMUNICATION AND SIGNALING (2021)

Article Immunology

Hepatitis B virus evades immune recognition via RNA adenosine deaminase ADAR1-mediated viral RNA editing in hepatocytes

Liyuan Wang et al.

Summary: ADAR1 interacts with HBV RNA to disrupt host immune recognition through deamination, promoting HBV replication. HBV X protein transcriptionally increases ADAR1 expression to raise the threshold for immune activation, enhancing HBV escape from immune recognition.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Review Immunology

The molecular mechanism of RIG-I activation and signaling*

Daniel Thoresen et al.

Summary: The article discusses specific activation of the RIG-I receptor by viral RNA and strategies for inactivation in the presence of host RNA, as well as the experimental evidence and evolutionary implications of RIG-I signaling. The researchers conclude by outlining the need for future cell biology and immunological investigations.

IMMUNOLOGICAL REVIEWS (2021)

Article Biochemistry & Molecular Biology

HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients

Bingqing Zheng et al.

Summary: NK cells play crucial roles in defending against HBV infection. However, dysfunction of NK cells in chronic hepatitis B virus infection is associated with decreased levels of STING adaptor. HBsAg inhibits STING expression in NK cells through the STAT3-STING axis, disrupting NK cell function in HBeAg-negative chronic HBV infection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, Research & Experimental

The NLRP3 inflammasome mediates liver failure by activating procaspase-1 and pro-IL-1 β and regulating downstream CD40-CD40L signaling

Zenghui Li et al.

Summary: This study found significant activation of the NLRP3 inflammasome in patients with HBV-ACLF, which mediates liver failure by stimulating procaspase-1 and pro-IL-1 beta, as well as regulating downstream CD40-CD40L signaling.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)

Review Virology

Viral proteins recognized by different TLRs

Rui Zhou et al.

Summary: Virus invasion triggers the host's innate immune response, leading to the production of cytokines and interferons to fight pathogens, and viral proteins are also recognized by pattern recognition receptors. Different TLRs play dual roles of protection and harm for specific viruses, and the relationship between TLRs and viral proteins is crucial for activating innate immunity.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Cell Biology

Cell biology of inflammasome activation

Abhimanu Pandey et al.

Summary: Organelles play a critical role in regulating and activating inflammasomes in cells, leading to inflammation and cell death. NLRP3 and Pyrin inflammasome sensors may aggregate at the microtubule-organizing center, activating various pathways that result in pyroptosis, cellular disintegration, and inflammation.

TRENDS IN CELL BIOLOGY (2021)

Review Virology

Advances in HBV infection and replication systems in vitro

Ruirui Xu et al.

Summary: Due to the presence of HBV cccDNA in host cells post-infection, current antiviral drugs are ineffective in eradicating HBV. Developing an active cell culture system supporting HBV infection is crucial for studying HBV and developing effective therapeutic drugs. Recent advancements in vitro offer hope for better understanding HBV biology, pathogenesis, drug screening, and carcinogenesis mechanisms.

VIROLOGY JOURNAL (2021)

Review Virology

Mechanism of Hepatitis B Virus cccDNA Formation

Lei Wei et al.

Summary: Hepatitis B virus (HBV) is a small DNA virus that undergoes a complex replication cycle in human hepatocytes to produce covalently closed circular DNA, relying on host factors for conversion. Research utilizing genetic and biochemical approaches has provided insights into the complex mechanism of HBV cccDNA formation, critical for the development of new therapies towards viral suppression and potential cure.

VIRUSES-BASEL (2021)

Article Virology

Innate immunity and HBV persistence

Carolina Chiale et al.

Summary: Understanding the relationship between HBV and innate immunity is crucial as the impact of HBV on the innate immune system plays a key role in chronic infection, and also influences adaptive immune mechanisms critical for control. These interactions could serve as useful immunotherapeutic targets to manage the infection.

CURRENT OPINION IN VIROLOGY (2021)

Review Pharmacology & Pharmacy

cGAS-STING Signaling Pathway and Liver Disease: From Basic Research to Clinical Practice

Bangjie Chen et al.

Summary: The cGAS-STING signaling pathway plays a significant role in liver diseases, inhibiting HBV replication and associated with tumor immunity in HCC. Its activation provides new insights for understanding and treating liver diseases.

FRONTIERS IN PHARMACOLOGY (2021)

Review Immunology

Interferon and Hepatitis B: Current and Future Perspectives

Jianyu Ye et al.

Summary: IFN therapy has unique advantages in treating chronic hepatitis B, but its efficacy is limited and side effects are common. To seek a cure for HBV, improving IFN therapy and combining it with other antiviral agents may be considered.

FRONTIERS IN IMMUNOLOGY (2021)

Review Immunology

The Functions of Hepatitis B Virus Encoding Proteins: Viral Persistence and Liver Pathogenesis

Fenglin Zhao et al.

Summary: Approximately 250 million people worldwide suffer from chronic Hepatitis B virus infection, leading to significant public health challenges. Despite available vaccines and antiviral drugs, curing chronic hepatitis B remains a distant goal. HBV-encoded proteins, including surface antigen, core antigen, envelope antigen, HBx, and polymerase, play crucial roles in viral persistence and liver pathogenesis, offering potential avenues for new CHB therapies.

FRONTIERS IN IMMUNOLOGY (2021)

Review Cell Biology

Anti-Viral Pattern Recognition Receptors as Therapeutic Targets

Conor Hennessy et al.

Summary: PRRs play a central role in inflammation following microbial infection by recognizing molecular patterns, and targeting them may offer a potential therapeutic approach for chronic inflammatory diseases and infections.
Review Biochemistry & Molecular Biology

Bridging Radiotherapy to Immunotherapy: The IFN-JAK-STAT Axis

Lewis Zhichang Shi et al.

Summary: Immunotherapies have shown success in late-stage cancer patients, leading to interest in the immunomodulatory effects of radiotherapy. The IFN-JAK-STAT pathway is identified as a major regulator, with signaling strength and duration potentially determining immunological outcomes. Targeting this pathway could enhance the immunostimulatory and radiosensitizing effects of combination therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

The JAK/STAT signaling pathway: from bench to clinic

Xiaoyi Hu et al.

Summary: The JAK/STAT signaling pathway is a crucial cellular signal transduction pathway, associated with various cancers and autoimmune diseases. Researchers discussed the composition, activation, and regulation of this pathway, as well as its role in diseases.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Immunology

Hepatitis B virus X Protein Promotes Liver Cancer Progression through Autophagy Induction in Response to TLR4 Stimulation

Juhee Son et al.

Summary: The HBx protein plays a key role in regulating autophagy in hepatocellular carcinoma (HCC) by inhibiting the BECN1-Bcl-2 complex and enhancing the TRAF6-BECN1-VPS34 complex. These mechanisms contribute to increased cell migration and invasion in liver cancer progression.

IMMUNE NETWORK (2021)

Review Gastroenterology & Hepatology

The role of cGAS-STING signalling in liver diseases

Ruihan Chen et al.

Summary: The cGAS-STING pathway activates innate immune responses by releasing cytokines to combat infections and diseases. It plays crucial roles in infectious diseases, inflammation, tumors, and autoimmune diseases, and influences the progression of liver inflammation.

JHEP REPORTS (2021)

Review Pharmacology & Pharmacy

Pharmacological Effects of Polyphenol Phytochemicals on the JAK-STAT Signaling Pathway

Qianqian Yin et al.

Summary: The JAK-STAT signaling pathway is closely related to cell proliferation, apoptosis, differentiation, and inflammatory response, essential for inhibiting inflammation, initiating innate immunity, and coordinating adaptive immune mechanisms. Various plant polyphenol compounds play a role in suppressing abnormal activation in the JAK-STAT pathway, showing significant effects in anti-inflammatory, antitumor, and cardiovascular disease control.

FRONTIERS IN PHARMACOLOGY (2021)

Review Immunology

The cGAS-STING pathway as a therapeutic target in inflammatory diseases

Alexiane Decout et al.

Summary: The cGAS-STING signaling pathway plays a crucial role in inflammation in infection, cellular stress, and tissue damage settings. It has the ability to sense and regulate cellular responses to DNA and has the potential to be targeted in the treatment of various inflammatory diseases.

NATURE REVIEWS IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Toll-like Receptors and the Control of Immunity

Katherine A. Fitzgerald et al.

Article Biochemistry & Molecular Biology

NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF

Yanhong Jia et al.

MOLECULAR IMMUNOLOGY (2020)

Review Pharmacology & Pharmacy

Mechanisms of HBV immune evasion

Adrian Kuipery et al.

ANTIVIRAL RESEARCH (2020)

Article Biochemistry & Molecular Biology

N6-Methyladenosine modification of hepatitis B and C viral RNAs attenuates host innate immunity via RIG-I signaling

Geon-Woo Kim et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Review Immunology

RIG-I-like receptors: their regulation and roles in RNA sensing

Jan Rehwinkel et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Immunology

Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma

Vivek K. Chaturvedi et al.

MICROBIAL PATHOGENESIS (2019)

Article Medicine, Research & Experimental

Hepatitis B virus X protein decreases nephrin expression and induces podocyte apoptosis via activating STAT3

Xiao-Yan Lei et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2019)

Article Virology

Hepatitis B core antigen can regulate NLRP3 inflammasome pathway in HepG2 cells

Xiaolin Ding et al.

JOURNAL OF MEDICAL VIROLOGY (2019)

Article Biotechnology & Applied Microbiology

Antagonism of RIP1 using necrostatin-1 (Nec-1) ameliorated damage and inflammation of HBV X protein (HBx) in human normal hepatocytes

Linsen Xie et al.

ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)

Article Medicine, Research & Experimental

HBx-related long non-coding RNA 01152 promotes cell proliferation and survival by IL-23 in hepatocellular carcinoma

Chen Tianshi et al.

BIOMEDICINE & PHARMACOTHERAPY (2019)

Review Biochemistry & Molecular Biology

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

Nathan Kelley et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Gastroenterology & Hepatology

Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses: Experimental Models and Molecular Mechanisms

Emmanuel Thomas et al.

SEMINARS IN LIVER DISEASE (2019)

Review Immunology

Role of AIM2 inflammasome in inflammatory diseases, cancer and infection

Bhesh Raj Sharma et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Article Microbiology

NF-κB-Dependent IFIT3 Induction by HBx Promotes Hepatitis B Virus Replication

Fengchao Xu et al.

FRONTIERS IN MICROBIOLOGY (2019)

Article Gastroenterology & Hepatology

Targeting Innate and Adaptive Immune Responses to Cure Chronic HBV Infection

Adam J. Gehring et al.

GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection

Barbara Rehermann et al.

GASTROENTEROLOGY (2019)

Review Biochemistry & Molecular Biology

Mechanisms of Hepatitis B Virus Persistence

Kuen-Nan Tsai et al.

TRENDS IN MICROBIOLOGY (2018)

Article Virology

Role of HBx in hepatitis B virus persistence and its therapeutic implications

Betty L. Slagle et al.

CURRENT OPINION IN VIROLOGY (2018)

Review Microbiology

When Hepatitis B Virus Meets Interferons

Guangyun Tan et al.

FRONTIERS IN MICROBIOLOGY (2018)

Review Biochemistry & Molecular Biology

Innate immunity related pathogen recognition receptors and chronic hepatitis B infection

Reza Nosratabadi et al.

MOLECULAR IMMUNOLOGY (2017)

Review Biochemistry & Molecular Biology

30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology

Qian Zhang et al.

Article Multidisciplinary Sciences

Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a

Zhaohua Hou et al.

SCIENTIFIC REPORTS (2016)

Article Cell Biology

Hepatitis B Virus X Protein Promotes Degradation of SMC5/6 to Enhance HBV Replication

Christopher M. Murphy et al.

CELL REPORTS (2016)

Article Medicine, Research & Experimental

Hepatitis B Virus X and Regulation of Viral Gene Expression

Betty L. Slagle et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

Article Biochemistry & Molecular Biology

Innate immune evasion by hepatitis B virus-mediated downregulation of TRIF

Yun Hong et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)

Article Gastroenterology & Hepatology

Molecular mechanism of hepatitis B virus X protein function in hepatocarcinogenesis

Ming Geng et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Article Cell Biology

Hepatitis B virus hijacks CTHRC1 to evade host immunity and maintain replication

Lan Bai et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2015)

Review Pharmacology & Pharmacy

The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease

Mark A. Feitelson et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2014)

Article Gastroenterology & Hepatology

Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways

Rong-Juan Pei et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma

Ashraf Ali et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Review Biochemistry & Molecular Biology

Unraveling the complexity of hepatitis B virus: From molecular understanding to therapeutic strategy in 50 years

Bo Liu et al.

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)

Article Medicine, Research & Experimental

Hepatitis B virus X protein modulates apoptosis in human renal proximal tubular epithelial cells by activating the JAK2/STAT3 signaling pathway

Ping He et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)

Article Biochemistry & Molecular Biology

HBx-dependent activation of twist mediates STAT3 control of epithelium-mesenchymal transition of liver cells

Jing Teng et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2013)

Article Gastroenterology & Hepatology

Hepatitis B virus HBx protein impairs liver regeneration through enhanced expression of IL-6 in transgenic mice

Ivan Quetier et al.

JOURNAL OF HEPATOLOGY (2013)

Article Biochemistry & Molecular Biology

The interaction between hepatitis B virus X protein and AIB1 oncogene is required for the activation of NFκB signal transduction

Andy Hong et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)

Review Cell Biology

Induction of type I IFNs by intracellular DNA-sensing pathways

Taner Cavlar et al.

IMMUNOLOGY AND CELL BIOLOGY (2012)

Article Medicine, Research & Experimental

Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor

Il-Rae Cho et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2012)

Article Gastroenterology & Hepatology

Hepatitis B virus X protein stimulates IL-6 expression in hepatocytes via a MyD88-dependent pathway

Wen-Qing Xiang et al.

JOURNAL OF HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

The hepatitis B e antigen suppresses IL-1β-mediated NF-κB activation in hepatocytes

R. Wilson et al.

JOURNAL OF VIRAL HEPATITIS (2011)

Article Multidisciplinary Sciences

Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells

Isabelle E. Vincent et al.

PLOS ONE (2011)

Review Biochemistry & Molecular Biology

Pattern Recognition Receptors and Inflammation

Osamu Takeuchi et al.

Article Biochemistry & Molecular Biology

The hepatitis B viral X protein activates NF-κB signaling pathway through the up-regulation of TBK1

Hye Rim Kim et al.

FEBS LETTERS (2010)

Article Biochemistry & Molecular Biology

NF-κB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx

T. M. Bui-Nguyen et al.

ONCOGENE (2010)

Article Biochemistry & Molecular Biology

Hepatitis B virus X protein enhances NFκB activity through cooperating with VBP1

Sang Yong Kim et al.

BMB REPORTS (2008)

Review Biochemistry & Molecular Biology

Shared principles in NF-κB signaling

Matthew S. Hayden et al.

Review Immunology

Viral evasion and subversion of pattern-recognition receptor signalling

Andrew G. Bowie et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Article Biotechnology & Applied Microbiology

Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat 1

Min Wu et al.

JOURNAL OF GENERAL VIROLOGY (2007)

Article Biochemistry & Molecular Biology

Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation

Shanshan Lin et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2007)

Article Gastroenterology & Hepatology

Regulation of toll-like receptor-2 expression in chronic hepatitis B by the precore protein

Kumar Visvanathan et al.

HEPATOLOGY (2007)

Article Biochemistry & Molecular Biology

The interaction of hepatitis B virus X protein and protein phosphatase type 2 Cα and its effect on IL-6

Ji Su Kim et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)

Article Immunology

Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B

Stephen M. Riordan et al.

CLINICAL AND VACCINE IMMUNOLOGY (2006)